Overview

Extracellular Fluid in Resistant Hypertension

Status:
Terminated

Trial end date:
2006-10-01

Target enrollment:

Participant gender:

Summary

The optimal treatment of drug resistant (defined as BP> 140/85 despite three anti-hypertensive drugs including a diuretic) is not well defined. This study aims to test the hypothesis that resistant hypertension is caused by excessive expansion of extracellular fluid volume. A secondary objective is to study which of three different antihypertensive drugs would be most useful in drug resistant hypertension.

Phase:

N/A

Details

Lead Sponsor:

St George's, University of London

Treatments:

Amiloride
Furosemide